PURCHASE, NY, Aug. 21, 2017 (GLOBE NEWSWIRE) -- Teladoc, Inc. (NYSE:TDOC), the world’s largest and most trusted telehealth provider, announced today that David Schloss has joined the company in the newly created role of chief human resources officer (CHRO). With extensive experience in global HR management across the pharmaceutical, biotech and consumer healthcare industries, Schloss will be instrumental in enabling Teladoc to support the increasing demands and requirements of the growing organization.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7da51e90-e699-4d61-b5d5-2c8fb31706f8
“As the Teladoc business has evolved and expanded, so too have our human resource needs, with now more than 1200 employees in locations around the world. It’s paramount that we build on our HR foundation to continue to meet the talent acquisition, employee development and associated compliance needs of a growing and diverse employee pool,” said Teladoc CEO, Jason Gorevic. “David not only has the requisite depth of experience and demonstrated leadership capability, but is also a strong cultural fit to join the ranks of our executive management team.”
Schloss has spent more than 25 years in the field of HR – the majority with public companies – and also has the distinction of being a labor and employment attorney, actively practicing law early in his career. He most recently held the position of Vice President of Human Resources at Caladrius Biosciences (formerly NeoStem), a leading clinical stage cell therapy company with products targeting autoimmune and cardiology indications. He was instrumental in helping grow Caladrius’ PCT cell therapy development and manufacturing business, as well as in the integration of a corporate acquisition. Prior to that he served in various executive level management positions in the pharmaceutical and biotech space, leading HR for a number of companies with responsibility for performance management, organizational design, global recruitment, restructuring, HRIS initiatives, and more. Schloss started his HR career and spent nearly 20 years with GlaxoSmithKline.
“In today's highly competitive global marketplace, attracting and retaining the best talent enables industry leaders like Teladoc to successfully execute on delivering on their mission and best serving their clients. I look forward to applying my expertise in building and expanding rapidly growing public companies to support the future of the Teladoc organization,” said Schloss.
About Teladoc, Inc.
Teladoc, Inc. (NYSE:TDOC) is the largest and most trusted telehealth provider in the world. Recognized by MIT Technology Review as one of the “50 Smartest Companies”, Teladoc is forging a new healthcare experience with an innovative portfolio of virtual care delivery solutions. Currently, Teladoc serves more than 10,000 clients – from payers to providers to employers – and more than 20 million members who connect within minutes to Teladoc’s network of more than 3,100 board-certified, state-licensed physicians and therapists, 24/7. Teladoc’s services and solutions marry a highly engaging consumer experience with the latest in data and analytics, and a highly flexible technology platform. Teladoc has delivered more than 2.5 million medical visits for general medical, dermatology, counseling, psychiatry, sexual health, and tobacco cessation. For additional information, please visit www.teladoc.com.